OREM, Utah, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (OTC:RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries announces a 27% year over year sales increase in Q3.
Cryometrix brand freezers have created a new market for the rapid, high volume freezing of blood and blood products. The increased interest in CAR T-cell therapy has driven pharmaceutical manufacturing to embrace blast freezing technologies like the B-90 blast freezer. The result has been an increase in year over year sales of 27% as Cryometrix freezer products continue to be recognized for their unmatched performance and utility. Mr. Boyce, CEO of Reflect, commented, “We had a great 3rd quarter and we expect the trend to continue. The interest in our freezer products continues to grow.”
Cryometrix is the brand name of the Reflect Scientific product line of liquid nitrogen powered freezers. No compressors and significantly fewer moving parts provides greater reliability. The freezers are differentiated in the market by their ability to reach low temperatures much more quickly than conventional compressor based freezers and maintain consistent temperatures within the container.
About Reflect Scientific, Inc.
Reflect Scientific, Inc., is a SEC fully reporting company. Based in Orem, Utah, the company develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific's products are low temperature freezers and refrigerated systems for laboratory, transportation and computer server room uses. Visit www.reflectscientific.com for more information.